Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hypertension × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 3 Inflammatory Bowel Diseases 2 Crohn Disease 2 Colitis, Ulcerative 2 Lymphoma 1 Inflammation 1 Hypertension 1 Depressive Disorder, Treatment-Resistant 1 Depressive Disorder, Major 1 Depression 1 Bipolar Disorder 1 Autoimmune Diseases 1 Arthritis, Psoriatic 1

Interventions

Osilodrostat 2 enzalutamide 1 clevidipine 1 bicalutamide 1 aliskiren 1 Tumor Necrosis Factors 1 Sodium Chloride 1 Receptors, Androgen 1 Leuprolide 1 Infliximab 1 Goserelin 1 Flutamide 1 Amlodipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743390 2017-11-09

Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension

University of Campinas, Brazil

Phase 4 Completed

Hypertension, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡